US equities |
SPCX $166.96 ▲+5.03% NVDA $237.14 ▲+1.36% MU $1,067.36 ▼-0.70% TSLA $375.61 ▲+1.35% MSFT $526.13 ▲+1.66% INTC $117.11 ▼-1.86% SNDK $1,725.03 ▲+0.29% META $742.86 ▲+2.03%
FinancialContent

Globus Medical, Inc. Class A Common Stock (NY:GMED)

75.83 +0.23 (+0.30%)
Delayed Quote Updated: 10:50 AM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Globus Medical Inc. (NYSE:GMED) Presents a Compelling Mix of Strong Fundamentals and Technical Setup ↗
Via Chartmill
News headline image
Globus Medical Announces Board Departure
From Globus Medical
Via GlobeNewswire
News headline image
1 Cash-Producing Stock to Target This Week and 2 That Underwhelm
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally ↗
Nuvalent develops targeted therapies for drug-resistant cancers, advancing clinical-stage candidates in precision oncology. 
Via The Motley Fool
Globus Medical Inc (NYSE:GMED): A GARP Stock with Strong Growth and a Reasonable Price ↗
Via Chartmill
Globus Medical Inc (NYSE:GMED) Beats Q4 Estimates and Raises 2026 EPS Guidance ↗
Via Chartmill
Globus Medical Inc (NYSE:GMED): A Prime Example of Affordable Growth ↗
Via Chartmill
Globus Medical Inc - A (NYSE:GMED) Shows Strong Fundamentals and Technical Setup for Growth ↗
Via Chartmill
News headline image
This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally ↗
This clinical-stage biotech develops small-molecule therapies targeting NASH, obesity, and related metabolic diseases. 
Via The Motley Fool
News headline image
2 Growth Stocks to Stash and 1 We Turn Down
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market va... 
Via StockStory
Topics Economy
News headline image
3 Healthcare Stocks to Target This Week
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have se... 
Via StockStory
Globus Medical Inc (NYSE:GMED) Emerges as a Minervini-Style Growth Momentum Candidate ↗
Via Chartmill
Globus Medical Inc (NYSE:GMED): A GARP Stock with Strong Growth and a Reasonable Price ↗
Via Chartmill
News headline image
Globus Medical (NYSE:GMED) Delivers Strong Q4 CY2025 Numbers
Medical device company Globus Medical (NYSE:GMED) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 25.7% year on year to $826.4 million. The company’s full-year revenue... 
Via StockStory
News headline image
Globus Medical Reports Fourth Quarter and Full Year 2025 Results
From Globus Medical
Via GlobeNewswire
News headline image
Globus Medical (GMED) Reports Earnings Tomorrow: What To Expect
Medical device company Globus Medical (NYSE:GMED) will be reporting results this Tuesday after market close. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence Government World Trade
News headline image
Inside a $75 Million Albertsons Stock Sale as Shares Sink 8% in a Year ↗
Albertsons operates a nationwide grocery network, pairing in-house food production with a broad mix of retail and pharmacy services. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
AvePoint Stock Down 47% as One Fund Slashes Stake by $65.9 Million ↗
This technology firm offers cloud-based data management and compliance tools for organizations using Microsoft 365 and other platforms. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Geneva Capital Dumps 95,000 OLLI Shares Worth $11.5 Million ↗
This off-price retailer leverages closeout sourcing to deliver brand-name merchandise at value prices across more than 450 U.S. stores. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
News headline image
1 Cash-Heavy Stock with Promising Prospects and 2 We Find Risky
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory
News headline image
2 Reasons to Watch GMED and 1 to Stay Cautious
What a fantastic six months it’s been for Globus Medical. Shares of the company have skyrocketed 62.5%, hitting $87.15. This was partly due to its solid quarterly results, and the run-up might have... 
Via StockStory
News headline image
Chart Industries Exit Comes With a $210 Takeout Clock and $6 Billion Backlog ↗
Chart Industries supplies cryogenic and heat transfer equipment to energy, industrial gas, and specialty markets worldwide. 
Via The Motley Fool
Topics Regulatory Compliance Supply Chain
News headline image
Knife River Stock Has Tumbled 31% This Past Year, but One Fund Placed a $22 Million Bet on a Turnaround ↗
Knife River delivers construction materials and services for large U.S. infrastructure projects, serving both public and private clients. 
Via The Motley Fool
News headline image
1 Safe-and-Steady Stock to Research Further and 2 That Underwhelm
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
News headline image
1 Mooning Stock to Keep an Eye On and 2 Facing Challenges
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
Via StockStory
Topics Bankruptcy
A Whole Watchlist of “Coiled Springs” (Found With One Simple ChartMill Screen) ↗
Via Chartmill
News headline image
2 Healthcare Stocks to Keep an Eye On and 1 We Ignore
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only... 
Via StockStory
Topics Stocks
News headline image
3 Profitable Stocks Worth Your Attention
Companies with solid operating margins have a competitive edge, allowing them to reinvest for sustainable expansion. The best of these businesses balance profitability with reinvestment, setting... 
Via StockStory
News headline image
Why Globus Medical Stock Is Flying Higher in After-Hours Trading ↗
Management sees a strong end to fiscal 2025. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >